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calculated by using fixed monitor units and the mean and the 
maximum dose to the oesophagus were read out. 
Results: The mean shift of the oesophagus was 7.5 mm ± 5.3 
mm with a maximum shift of 23.3 mm. In seven patients 
shifts above 10 mm was observed in one or both control 
scans. The mean shift in the region of the tumour was 3.8 
mm ± 3.0 mm with a maximum shift of 13.5 mm. Two 
patients showed shifts of the oesophagus above 10 mm and in 
both patients an atelectasis disappeared during the 
treatment course, whereby the anatomy of the patient 
changed. The mean dose to the oesophagus at the region of 
the tumour (eso-T) increased by 0.4% ± 4.4% when the plan 
was evaluated at the control scans. In three patients, an 
increase in mean dose above 5% was observed. These patients 
have anatomically changes such as pneumonia and 
atelectasis. The maximum dose increased by 1.3% ± 2.6%, 
with a maximum increase of 10% in one patient. In this 
patient only minor anatomical changes are observed. 
Conclusions: The oesophagus moves during the RT course. In 
three patients, the mean dose to the oesophagus in the 
tumour region increases with more than 5 % which can 
correlate with shifts above 10 mm of the oesophagus in two 
of the patients. Patients with anatomical changes like 
disappearance of an atelectasis are more likely to receive an 
increased dose to the oesophagus during the RT course. In 
the case of dose escalation, these patients may benefit from 
an adaptive treatment plan during treatment to avoid severe 
oesophageal toxicity. 
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Purpose/Objective: To compare the accuracy of our 
conventional set-up technique using MV imaging to an optical 
surface monitoring set up (OSMS®, Varian) for the treatment 
of breast cancer patients. Additionally, we evaluated possible 
changes in breast shape during the course of treatment. 
Materials and Methods: 7 breast cancer patients were 
treated using 3D tangential fields. Patients were positioned 
supine on the breast board according to the external 
isocenter marks. MV imaging and bone match on the chest 
wall was done to adjust the position. To track the patients' 
shifts during the matching procedure, OSMS was used. The 
OSMS system consists of 6 cameras, which acquire the 
patients' position in 2D, and a computer vision algorithm, 
which reconstructs the image in 3D. The patients' reference 
surface was imported from the CT scan and the region of 
interest of the treated area was selected. Before and after 
applying the table shifts based on the 2D MV match, the 
treatment surface was captured in order to monitor the OSMS 
corrections in all the translational and rotational directions. 
The OSMS deltas were compared before performing the couch 
and MV imaging shifts. Additionally, the difference between 
the OSMS deltas were calculated, before and after the couch 
shifts, and then compared to the MV imaging shifts. 
Results: Mean shift difference between MV and OSMS in the 
vertical axis was: 2.3mm ± 2.1mm, in the longitudinal axis 
1.9mm ± 2.9mm, in the lateral axis 0.9mm ± 4.2mm. The 
maximum differences were as follows: vertical 8.0mm, 
longitudinal 8.4mm, and lateral 13.2mm.OSMS showed 
rotation up to 3.5°, roll to 4.6°, and pitch 3.1°. 6 out of 7 
patients showed differences less than 1cm between the 
imaging techniques, which were attributed to changes based 
on swelling and arm position. One patient showed a mean 
lateral discrepancy of 9.3mm during the 13 fractions, which 
was most likely due to a variation in roll and rotation at the 
initial CT. The mean absolute difference between the shift 
registered by OSMS after performing the couch movement 
and the shift from MV imaging was: 0.93mm ± 0.78mm in the 
vertical direction, 0.94mm ± 0.75mm in the longitudinal, and 
0.7mm ± 1.0mm in the lateral. 
Conclusions: The OSMS system is helpful in detecting 
differences between treatment and initial setup during CT 
simulation such as arm position or patient rotation. 
Additionally, changes to the breast, such as swelling, can be 
detected. This is especially important if intensity modulated 
techniques are applied. Therefore, using OSMS as an 
additional device to monitor interfractional motion provides 
useful information leading to more precise positioning of the 
patients. This may eventually result in being able to apply 
tighter margins. 
   
PO-1114   
A multidisciplinary developed optimized imaging strategy 
for frameless stereotactic radiosurgery 
M. McGarry1, T. El Kaissi1, J. Hayes1, M. Riyas1, K. Benson1, S. 
Paloor1, J. McLellan1, S. Sheim1, G. Perkins1, R. Hammoud1, 
P. Petric1, N. Al-Hammadi1 
1Hamad Medical Corporation Al Amal Oncology Centre, 
Radiation Oncology, Doha, Qatar  
 
Purpose/Objective: To determine the optimum online 
imaging strategy for frameless SRS using ExacTrac based on 
system accuracy, clinically observed discrepancies between 
imaging methods and intrafraction motion of the patient in 
the frameless mask. 
Materials and Methods: The ExacTrac (ET) system was 
calibrated using the Winston Lutz test to match the ET 
imaging and treatment isocenters to within sub-millimeter 
accuracy as part of acceptance and commissioning. This 
provided a benchmark for our imaging system. A task based 
approach was adopted to develop an optimised imaging 
strategy and associated work instructions. A pilot protocol 
was implemented for six patients, in which both online cone 
beam CT (CBCT) and ET based x-ray verification was 
performed for 24 fractions, with six degrees of freedom 
within the Brainlab system. From analysis of this data, the 
imaging strategy was amended and ET only based verification 
was then carried out for a further 14 patients. In addition, 
intrafraction motion was determined for 89 fractions 
quantifying the stability of the masking system and the 
frequency of verification imaging required. 
Results: The benchmarking QA process determined typical 
deviations of ~0.5mm between the radiation and imaging 
isocentres. Agreement between CBCT and ET verification was 
less than 0.6mm and 0.5degrees which improved our 
confidence with the procedure (Fig.1). 
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The CBCT step was eliminated which streamlined the clinical 
protocol as CBCT verification is limited to couch zero. The 
treatment time was reduced by 5-7 minutes per fraction and 
the dose at the verification step reduced from c.72mGy to c. 
0.335mGy (AAPM TG 75). Patient intrafraction data was 
benchmarked against the 1mm accuracy delivered by the 
conventional frame based radiosurgery. The results 
demonstrate that this criteria was met, with all translational 
errors well below 1mm and rotational errors below 
0.5degrees which we use as the online tolerance for 
treatment delivery (Table 1). 
  
 
 
Conclusions: As per previous studies a modest difference 
between ET x-ray and CBCT corrections was found in patient 
data but not in phantom testing, even though in this study 
both sets of images were analyzed with six degrees of 
freedom in the Brainlab software. The difference is due to 
inherent differences in the modalities, as it cannot be fully 
accounted for by intrafraction motion. The imaging strategy 
was optimized and streamlined, informed by the quantified 
stability of the masking system and the optimum positioning 
verification modality for cranial SRS procedures. 
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Purpose/Objective: Radical radiotherapy with hypo-
fractionated (HF) regimen is used in some busy centres for 
the treatment of early glottic cancers (EGC). We at our 
centre conducted an audit of the EGC treated with HF 
regimen and analysed the factors impacting local control. 
Materials and Methods: 59 unselected patients of 
histologically confirmed glottis squamous cell cancer patients 
treated during September 2011 to July 2014, were analysed. 
Only patients with stage T1/ T2 N0 as per the 7th edition of 
AJCC and who were treated using a HF regimen of 5500cGy 
delivered in 20 were included. Only patients with a minimum 
follow up of six months, n=56, were analysed. The outcomes 
and treatment as well as tumour related factors associated 
were systematically analysed and correlated to outcome. We 
also did an audit of the online matching of the carotid 
sparing (CS) cohort to analyse the importance of residual 
errors and its impact on local control. 
Results: This analysis was done at a median follow up of 18 
months. 89.3% of the patients were T1 and 10.7% were T2. 
57.1% patients were treated using IMRT (93.8% helical 
tomotherapy (HT) and 6.2% VMAT), the remaining were 
treated using 3DCRT. 18 patients in the IMRT group had 
undergone carotid sparing (CS) as part of a prospective study. 
A bolus was required for dose build up in the anterior 
commissure (AC) region in 72.7% patients with a risk of 
involvement to that area. All patients achieved a complete 
response at the first post radiation visit 4-6 weeks post 
therapy. 7 patients had grade 2 or more dermatitis.15 
patients (26.8%) developed grade 2 or more dysphagia. 
Overall 10.7% patients had failure of treatment with 5 
patients having a local recurrence and 1 patient failing 
regionally in the nodal region. One patient died of an 
unrelated medical condition. Clinical stage did not have any 
significant bearing on the control rates (T1a vs T1b vs T2 8.6% 
vs 13.3% vs 16.7%; p=0.8). All failures occurred in the IMRT 
group with 10.7% failures overall and 18.7% within the group. 
All failures occurred in the HT IMRT arm (5/6 had disease 
involving AC, anterior cord (1/6)). CS was significantly 
associated with failure with 5/6 recurrence occurring in this 
group (p=0.005). The PTV indices D99 (p=0.01), D50 (p=0.001) 
and HI (p=0.004) were significantly better in those who 
failed. Other treatment related factors like the AC 
involvement, prolongation of the duration of radiation course 
did not have significant relation with the outcome. Also the 
online matching of the patients who had undergone CS was 
done to analyse the impact of errors in matching. Residual 
errors were calculated for these patients based on the offline 
matching shift data. None of the residual translational errors 
turned out to be significantly related to recurrence in the 18 
patients in the carotid spared group. 
Conclusions: Hypofractionated radiotherapy is safe with 
acceptable toxicity rates and good overall control. However 
in tumors with anterior extension there may be higher chance 
of failure. Good image guidance protocols with proper 
placement and matching of bolus is very important. 
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